Colpaert et al., 2019 - Google Patents
MicroRNAs in cardiac diseasesColpaert et al., 2019
View HTML- Document ID
- 16807479074439510607
- Author
- Colpaert R
- Calore M
- Publication year
- Publication venue
- Cells
External Links
Snippet
Since their discovery 20 years ago, microRNAs have been related to posttranscriptional regulation of gene expression in major cardiac physiological and pathological processes. We know now that cardiac muscle phenotypes are tightly regulated by multiple noncoding …
- 229920001239 microRNA 0 title abstract description 165
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Colpaert et al. | MicroRNAs in cardiac diseases | |
Haque et al. | Circular RNAs (circRNAs) in health and disease | |
Iaconetti et al. | Non-coding RNAs: the “dark matter” of cardiovascular pathophysiology | |
Hasimbegovic et al. | Alternative splicing in cardiovascular disease—a survey of recent findings | |
Dill et al. | A hearty dose of noncoding RNAs: the imprinted DLK1-DIO3 locus in cardiac development and disease | |
Van der Hauwaert et al. | Non-Coding RNAs as new therapeutic targets in the context of renal fibrosis | |
Pérez-García et al. | Posttranscriptional regulation of insulin resistance: implications for metabolic diseases | |
Chiti et al. | MicroRNAs in hypertrophic, arrhythmogenic and dilated cardiomyopathy | |
Han et al. | Role of long non-coding RNAs in pulmonary arterial hypertension | |
Bley et al. | Musashi–1—A Stemness RBP for Cancer Therapy? | |
Kinoshita et al. | Interplay of RNA-binding proteins and microRNAs in neurodegenerative diseases | |
Srivastava et al. | Interactions among long non-coding RNAs and microRNAs influence disease phenotype in diabetes and diabetic kidney disease | |
Improta-Caria et al. | MicroRNAs regulating renin–angiotensin–aldosterone system, sympathetic nervous system and left ventricular hypertrophy in systemic arterial hypertension | |
Shaffi et al. | Role of microRNAs in renal parenchymal diseases—a new dimension | |
Prestes et al. | A guide to the short, long and circular RNAs in hypertension and cardiovascular disease | |
Singh et al. | Non-coding RNAs in regulating plaque progression and remodeling of extracellular matrix in atherosclerosis | |
Singh et al. | Clinical significance of MicroRNAs, long non-coding RNAs, and CircRNAs in cardiovascular diseases | |
Zhang et al. | The role of circular RNAs in the physiology and pathology of the mammalian ovary | |
Hitachi et al. | The functional role of long non-coding RNA in myogenesis and skeletal muscle atrophy | |
Park et al. | MicroRNAs and calcium signaling in heart disease | |
Yoshikawa et al. | Identification of candidate genes and pathways in dexmedetomidine-induced cardioprotection in the rat heart by bioinformatics analysis | |
Szostak et al. | The role of microRNA in the pathogenesis of diabetic nephropathy | |
Kennel et al. | A review on the evolving roles of MiRNA-based technologies in diagnosing and treating heart failure | |
Caus et al. | Role of microRNAs in obesity-related kidney disease | |
Soubise et al. | RBM22, a key player of pre-mRNA splicing and gene expression regulation, is altered in cancer |